{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:16:02Z","timestamp":1793042162190,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Clostridium difficile<\/jats:italic> is the leading cause of nosocomial diarrhea and colitis in the industrialized world. Disruption of the protective gut microbiota by antibiotics enables colonization by multidrug-resistant <jats:italic>C. difficile<\/jats:italic>, which secrete up to three different protein toxins that are responsible for the gastrointestinal sequelae. Oral agents that inhibit the damage induced by toxins, without altering the gut microbiota, are urgently needed to prevent primary disease and break the cycle of antibiotic-induced disease recurrence. Here, we show that the anthelmintic drug, niclosamide, inhibits the pathogenesis of all three toxins by targeting a host process required for entry into colonocytes by each toxin. In mice infected with an epidemic strain of <jats:italic>C. difficile<\/jats:italic>, expressing all three toxins, niclosamide reduced both primary disease and recurrence, without disrupting the diversity or composition of the gut microbiota. Given its excellent safety profile, niclosamide may address an important unmet need in preventing <jats:italic>C. difficile<\/jats:italic> primary and recurrent diseases.<\/jats:p>","DOI":"10.1038\/s41467-018-07705-w","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T10:14:30Z","timestamp":1543832070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota"],"prefix":"10.1038","volume":"9","author":[{"given":"John","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therwa","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5120-6119","authenticated-orcid":false,"given":"Kevin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg L.","family":"Beilhartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-2233","authenticated-orcid":false,"given":"Jacques","family":"Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A.","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"7705_CR1","doi-asserted-by":"crossref","unstructured":"Theriot, C. M., Bowman, A. A. & Young, V. B. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1, 00045\u201315 (2016).","DOI":"10.1128\/mSphere.00045-15"},{"key":"7705_CR2","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald, L. C. et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353, 2433\u20132441 (2005).","journal-title":"N. Engl. J. Med."},{"key":"7705_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/592257","volume":"47","author":"A Goorhuis","year":"2008","unstructured":"Goorhuis, A. et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47, 1162\u20131170 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"7705_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/gmic.26854","volume":"5","author":"DN Gerding","year":"2014","unstructured":"Gerding, D. N., Johnson, S., Rupnik, M. & Aktories, K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5, 15\u201327 (2014).","journal-title":"Gut Microbes"},{"key":"7705_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.2478","volume":"45","author":"M He","year":"2013","unstructured":"He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109\u2013113 (2013).","journal-title":"Nat. Genet."},{"key":"7705_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"366","author":"M Warny","year":"2005","unstructured":"Warny, M. et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079\u20131084 (2005).","journal-title":"Lancet"},{"key":"7705_CR7","doi-asserted-by":"crossref","unstructured":"Collins, J. et al. Dietary trehalose enhances virulence of epidemic Clostridium difficile. Nature 291\u2013294 (2018).","DOI":"10.1038\/nature25178"},{"key":"7705_CR8","doi-asserted-by":"publisher","first-page":"e1001061","DOI":"10.1371\/journal.ppat.1001061","volume":"6","author":"JM Lanis","year":"2010","unstructured":"Lanis, J. M., Barua, S. & Ballard, J. D. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog. 6, e1001061 (2010).","journal-title":"PLoS Pathog."},{"key":"7705_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nature07822","volume":"458","author":"D Lyras","year":"2009","unstructured":"Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176\u20131179 (2009).","journal-title":"Nature"},{"key":"7705_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nature09397","volume":"467","author":"SA Kuehne","year":"2010","unstructured":"Kuehne, S. A. et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711\u2013713 (2010).","journal-title":"Nature"},{"key":"7705_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/infdis\/jit426","volume":"209","author":"SA Kuehne","year":"2014","unstructured":"Kuehne, S. A. et al. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J. Infect. Dis. 209, 83\u201386 (2014).","journal-title":"J. Infect. Dis."},{"key":"7705_CR12","unstructured":"Louie, T. M. et al. Clostridium difficile-associated diarrhea (CDAD). in Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, poster K-425a, p. 212 (American Society for Microbiology, Washington, DC, 2007)."},{"key":"7705_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/IAI.02550-14","volume":"83","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect. Immun. 83, 405\u2013416 (2015).","journal-title":"Infect. Immun."},{"key":"7705_CR14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/phar.1990","volume":"37","author":"WD Kufel","year":"2017","unstructured":"Kufel, W. D., Devanathan, A. S., Marx, A. H., Weber, D. J. & Daniels, L. M. Bezlotoxumab: a novel agent for the prevention of recurrent Clostridium difficile infection. Pharmacotherapy 37, 1298\u20131308 (2017).","journal-title":"Pharmacotherapy"},{"key":"7705_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox, M. H. et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N. Engl. J. Med. 376, 305\u2013317 (2017).","journal-title":"N. Engl. J. Med."},{"key":"7705_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.anaerobe.2017.10.008","volume":"48","author":"Patrizia Spigaglia","year":"2017","unstructured":"Spigaglia, P. et al. Clostridium difficile causing pediatric infections: new findings from a hospital-based study in Italy. Anaerobe 262\u2013268 (2017).","journal-title":"Anaerobe"},{"key":"7705_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.anaerobe.2015.11.002","volume":"37","author":"P Spigaglia","year":"2016","unstructured":"Spigaglia, P., Barbanti, F., Morandi, M., Moro, M. L. & Mastrantonio, P. Diagnostic testing for Clostridium difficile in Italian microbiological laboratories. Anaerobe 37, 29\u201333 (2016).","journal-title":"Anaerobe"},{"key":"7705_CR18","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1128\/JCM.01810-15","volume":"53","author":"GO Androga","year":"2015","unstructured":"Androga, G. O. et al. Infection with toxin A-negative, toxin B-negative, binary toxin-positive Clostridium difficile in a young patient with ulcerative colitis. J. Clin. Microbiol. 53, 3702\u20133704 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"7705_CR19","first-page":"235","volume":"39","author":"S Grandesso","year":"2016","unstructured":"Grandesso, S. et al. Clostridium difficile ribotype 033 colitis in a patient following broad-spectrum antibiotic treatment for KPC producing Klebsiella pneumoniae infection, Italy. New Microbiol. 39, 235\u2013236 (2016).","journal-title":"New Microbiol."},{"key":"7705_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nmni.2014.10.003","volume":"3","author":"C Eckert","year":"2015","unstructured":"Eckert, C. et al. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect. 3, 12\u201317 (2015).","journal-title":"New Microbes New Infect."},{"key":"7705_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/AAC.00618-10","volume":"55","author":"CZ Chen","year":"2011","unstructured":"Chen, C. Z. et al. High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements. Antimicrob. Agents Chemother. 55, 667\u2013675 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7705_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","volume":"22","author":"M Xu","year":"2016","unstructured":"Xu, M. et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med. 22, 1101\u20131107 (2016).","journal-title":"Nat. Med."},{"key":"7705_CR23","doi-asserted-by":"publisher","first-page":"290ra289","DOI":"10.1126\/scitranslmed.aaa5597","volume":"7","author":"LM Johansen","year":"2015","unstructured":"Johansen, L. M. et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 7, 290ra289 (2015).","journal-title":"Sci. Transl. Med."},{"key":"7705_CR24","doi-asserted-by":"publisher","first-page":"282ra249","DOI":"10.1126\/scitranslmed.3010286","volume":"7","author":"S He","year":"2015","unstructured":"He, S. et al. Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection. Sci. Transl. Med. 7, 282ra249 (2015).","journal-title":"Sci. Transl. Med."},{"key":"7705_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.7326\/0003-4819-102-4-550","volume":"102","author":"RD Pearson","year":"1985","unstructured":"Pearson, R. D. & Hewlett, E. L. Niclosamide therapy for tapeworm infections. Ann. Intern. Med. 102, 550\u2013551 (1985).","journal-title":"Ann. Intern. Med."},{"key":"7705_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","volume":"19","author":"P Andrews","year":"1982","unstructured":"Andrews, P., Thyssen, J. & Lorke, D. The biology and toxicology of molluscicides, Bayluscide. Pharmacol. Ther. 19, 245\u2013295 (1982).","journal-title":"Pharmacol. Ther."},{"key":"7705_CR27","first-page":"1","volume":"13","author":"G Hecht","year":"1962","unstructured":"Hecht, G. & Gloxhuber, C. [Studies on the tolerance of 5,2\u2032-dichloro-4\u2032-nitrosalicylanilide ethanolamine salt]. Z. Trop. Parasitol. 13, 1\u20138 (1962).","journal-title":"Z. Trop. Parasitol."},{"key":"7705_CR28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/jcm.15.6.1157-1158.1982","volume":"15","author":"ST Donta","year":"1982","unstructured":"Donta, S. T., Sullivan, N. & Wilkins, T. D. Differential effects of Clostridium difficile toxins on tissue-cultured cells. J. Clin. Microbiol. 15, 1157\u20131158 (1982).","journal-title":"J. Clin. Microbiol."},{"key":"7705_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1046\/j.1462-5822.2002.00201.x","volume":"4","author":"M Qa\u2019Dan","year":"2002","unstructured":"Qa\u2019Dan, M. et al. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell. Microbiol. 4, 425\u2013434 (2002).","journal-title":"Cell. Microbiol."},{"key":"7705_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.chembiol.2014.12.010","volume":"22","author":"J Tam","year":"2015","unstructured":"Tam, J. et al. Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage. Chem. Biol. 22, 175\u2013185 (2015).","journal-title":"Chem. Biol."},{"key":"7705_CR31","doi-asserted-by":"publisher","first-page":"e000030","DOI":"10.1136\/esmoopen-2015-000030","volume":"1","author":"A Eniu","year":"2016","unstructured":"Eniu, A., Torode, J., Magrini, N. & Bricalli, G., Union for International Cancer Control EML Steering Committee Members. Back to the \u2018essence\u2019 of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines. ESMO Open 1, e000030 (2016).","journal-title":"ESMO Open"},{"key":"7705_CR32","doi-asserted-by":"publisher","first-page":"18674","DOI":"10.1073\/pnas.1313658110","volume":"110","author":"MA Farrow","year":"2013","unstructured":"Farrow, M. A. et al. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc. Natl. Acad. Sci. U.S.A. 110, 18674\u201318679 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"7705_CR33","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1073\/pnas.1400680111","volume":"111","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc. Natl. Acad. Sci. U.S.A. 111, 3721\u20133726 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"7705_CR34","doi-asserted-by":"publisher","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","volume":"8","author":"A Jurgeit","year":"2012","unstructured":"Jurgeit, A. et al. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 8, e1002976 (2012).","journal-title":"PLoS Pathog."},{"key":"7705_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep33642","volume":"6","author":"M Gooyit","year":"2016","unstructured":"Gooyit, M. & Janda, K. D. Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile. Sci. Rep. 6, 33642 (2016).","journal-title":"Sci. Rep."},{"key":"7705_CR36","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1016\/j.bmc.2013.08.029","volume":"21","author":"K Pauk","year":"2013","unstructured":"Pauk, K. et al. New derivatives of salicylamides: preparation and antimicrobial activity against various bacterial species. Bioorg. Med. Chem. 21, 6574\u20136581 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"7705_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.anaerobe.2017.02.006","volume":"44","author":"CJ Hastey","year":"2017","unstructured":"Hastey, C. J. et al. Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods. Anaerobe 44, 73\u201377 (2017).","journal-title":"Anaerobe"},{"key":"7705_CR38","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1099\/mic.0.042010-0","volume":"156","author":"GW Tannock","year":"2010","unstructured":"Tannock, G. W. et al. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology 156, 3354\u20133359 (2010).","journal-title":"Microbiology"},{"key":"7705_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"7705_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings, C. & Riley, T. V. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J. Antimicrob. Chemother. 69, 881\u2013891 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"7705_CR41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.tim.2015.10.009","volume":"23","author":"GL Beilhartz","year":"2015","unstructured":"Beilhartz, G. L., Tam, J. & Melnyk, R. A. Small molecules take a big step against Clostridium difficile. Trends Microbiol. 23, 746\u2013748 (2015).","journal-title":"Trends Microbiol."},{"key":"7705_CR42","doi-asserted-by":"publisher","first-page":"370tc372","DOI":"10.1126\/scitranslmed.aad8926","volume":"8","author":"GL Beilhartz","year":"2016","unstructured":"Beilhartz, G. L., Tam, J., Zhang, Z. & Melnyk, R. A. Comment on \u201cA small-molecule antivirulence agent for treating Clostridium difficile infection\u201d. Sci. Transl. Med. 8, 370tc372 (2016).","journal-title":"Sci. Transl. Med."},{"key":"7705_CR43","doi-asserted-by":"publisher","first-page":"306ra148","DOI":"10.1126\/scitranslmed.aac9103","volume":"7","author":"KO Bender","year":"2015","unstructured":"Bender, K. O. et al. A small-molecule antivirulence agent for treating Clostridium difficile infection. Sci. Transl. Med. 7, 306ra148 (2015).","journal-title":"Sci. Transl. Med."},{"key":"7705_CR44","doi-asserted-by":"publisher","first-page":"e00551","DOI":"10.1128\/mBio.00551-15","volume":"6","author":"GP Carter","year":"2015","unstructured":"Carter, G. P. et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. mBio 6, e00551 (2015).","journal-title":"mBio"},{"key":"7705_CR45","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3892\/ijmm.2016.2689","volume":"38","author":"MA Suliman","year":"2016","unstructured":"Suliman, M. A. et al. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family. Int. J. Mol. Med. 38, 776\u2013784 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"7705_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2017.01.140","volume":"484","author":"L Chen","year":"2017","unstructured":"Chen, L., Wang, L., Shen, H., Lin, H. & Li, D. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem. Biophys. Res. Commun. 484, 416\u2013421 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7705_CR47","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3892\/ol.2017.6372","volume":"14","author":"M Xiang","year":"2017","unstructured":"Xiang, M. et al. Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1alpha\/vascular endothelial growth factor signaling pathway in human lung cancer cells. Oncol. Lett. 14, 1933\u20131938 (2017).","journal-title":"Oncol. Lett."},{"key":"7705_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1159\/000490140","volume":"47","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. Niclosamide exhibits potent anticancer activity and synergizes with sorafenib in human renal cell cancer cells. Cell. Physiol. Biochem. 47, 957\u2013971 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"7705_CR49","first-page":"3497","volume":"17","author":"Y Zuo","year":"2018","unstructured":"Zuo, Y. et al. Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. Mol. Med. Rep. 17, 3497\u20133502 (2018).","journal-title":"Mol. Med. Rep."},{"key":"7705_CR50","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm.3699","volume":"20","author":"H Tao","year":"2014","unstructured":"Tao, H., Zhang, Y., Zeng, X., Shulman, G. I. & Jin, S. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat. Med. 20, 1263\u20131269 (2014).","journal-title":"Nat. Med."},{"key":"7705_CR51","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.18632\/oncotarget.7113","volume":"7","author":"CK Lin","year":"2016","unstructured":"Lin, C. K. et al. Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer. Oncotarget 7, 8993\u20139006 (2016).","journal-title":"Oncotarget"},{"key":"7705_CR52","doi-asserted-by":"publisher","first-page":"12709","DOI":"10.1039\/C7NR01973D","volume":"9","author":"J Bhattacharyya","year":"2017","unstructured":"Bhattacharyya, J. et al. Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. Nanoscale 9, 12709\u201312717 (2017).","journal-title":"Nanoscale"},{"key":"7705_CR53","doi-asserted-by":"publisher","first-page":"170611","DOI":"10.1098\/rsos.170611","volume":"4","author":"S Naqvi","year":"2017","unstructured":"Naqvi, S., Mohiyuddin, S. & Gopinath, P. Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy. R. Soc. Open Sci. 4, 170611 (2017).","journal-title":"R. Soc. Open Sci."},{"key":"7705_CR54","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41385-018-0008-5","volume":"11","author":"TP Brosschot","year":"2018","unstructured":"Brosschot, T. P. & Reynolds, L. A. The impact of a helminth-modified microbiome on host immunity. Mucosal Immunol. 11, 1039\u20131046 (2018).","journal-title":"Mucosal Immunol."},{"key":"7705_CR55","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/infdis\/jix141","volume":"215","author":"LA Reynolds","year":"2017","unstructured":"Reynolds, L. A. et al. Enteric helminths promote Salmonella coinfection by altering the intestinal metabolome. J. Infect. Dis. 215, 1245\u20131254 (2017).","journal-title":"J. Infect. Dis."},{"key":"7705_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2180-8-192","volume":"8","author":"G Yang","year":"2008","unstructured":"Yang, G. et al. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol. 8, 192 (2008).","journal-title":"BMC Microbiol."},{"key":"7705_CR57","doi-asserted-by":"publisher","first-page":"22731","DOI":"10.1074\/jbc.270.39.22731","volume":"270","author":"S Bagrodia","year":"1995","unstructured":"Bagrodia, S., Taylor, S. J., Creasy, C. L., Chernoff, J. & Cerione, R. A. Identification of a mouse p21Cdc42\/Rac activated kinase. J. Biol. Chem. 270, 22731\u201322737 (1995).","journal-title":"J. Biol. Chem."},{"key":"7705_CR58","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/cb300555n","volume":"8","author":"LH Slater","year":"2013","unstructured":"Slater, L. H. et al. Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death. ACS Chem. Biol. 8, 812\u2013822 (2013).","journal-title":"ACS Chem. Biol."},{"key":"7705_CR59","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/nprot.2007.321","volume":"2","author":"FH Niesen","year":"2007","unstructured":"Niesen, F. H., Berglund, H. & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2, 2212\u20132221 (2007).","journal-title":"Nat. Protoc."},{"key":"7705_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.micpath.2014.01.001","volume":"67-68","author":"PM Ireland","year":"2014","unstructured":"Ireland, P. M., Marshall, L., Norville, I. & Sarkar-Tyson, M. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei. Microb. Pathog. 67-68, 55\u201358 (2014).","journal-title":"Microb. Pathog."},{"key":"7705_CR61","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","volume":"135","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135, 1984\u20131992 (2008).","journal-title":"Gastroenterology"},{"key":"7705_CR62","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1128\/IAI.00215-12","volume":"80","author":"H Wang","year":"2012","unstructured":"Wang, H. et al. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect. Immun. 80, 2678\u20132688 (2012).","journal-title":"Infect. Immun."},{"key":"7705_CR63","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/IAI.02897-14","volume":"83","author":"Z Yang","year":"2015","unstructured":"Yang, Z. et al. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab. Infect. Immun. 83, 822\u2013831 (2015).","journal-title":"Infect. Immun."},{"key":"7705_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/19490976.2015.1062965","volume":"6","author":"Z Yang","year":"2015","unstructured":"Yang, Z., Zhang, Y., Huang, T. & Feng, H. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis. Gut Microbes 6, 221\u2013224 (2015).","journal-title":"Gut Microbes"},{"key":"7705_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-6","volume":"2","author":"DW Fadrosh","year":"2014","unstructured":"Fadrosh, D. W. et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2, 6 (2014).","journal-title":"Microbiome"},{"key":"7705_CR66","unstructured":"Wu, Y. Barcode demultiplex for Illumina I1, R1, R2 fastq.gz files (https:\/\/github.com\/yhwu\/idemp). (2014)."},{"key":"7705_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-341","volume":"11","author":"R Schmieder","year":"2010","unstructured":"Schmieder, R., Lim, Y. W., Rohwer, F. & Edwards, R. TagCleaner: identification and removal of tag sequences from genomic and metagenomic datasets. BMC Bioinformatics 11, 341 (2010).","journal-title":"BMC Bioinformatics"},{"key":"7705_CR68","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"7705_CR69","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/bioinformatics\/btv401","volume":"31","author":"RC Edgar","year":"2015","unstructured":"Edgar, R. C. & Flyvbjerg, H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics 31, 3476\u20133482 (2015).","journal-title":"Bioinformatics"},{"key":"7705_CR70","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ismej.2011.139","volume":"6","author":"D McDonald","year":"2012","unstructured":"McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610\u2013618 (2012).","journal-title":"ISME J."},{"key":"7705_CR71","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ismej.2008.44","volume":"2","author":"SJ Bent","year":"2008","unstructured":"Bent, S. J. & Forney, L. J. The tragedy of the uncommon: understanding limitations in the analysis of microbial diversity. ISME J. 2, 689\u2013695 (2008).","journal-title":"ISME J."},{"key":"7705_CR72","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217 (2013).","journal-title":"PLoS One"},{"key":"7705_CR73","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal, W. H. & Wallis, W. A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583\u2013621 (1952).","journal-title":"J. Am. Stat. Assoc."},{"issue":"2","key":"7705_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1469-1809.1936.tb02137.x","volume":"7","author":"R. A. FISHER","year":"1936","unstructured":"Fisher, R. A. The use of multiple measurements in taxonomic problems. Ann. Hum. Genet. 7, 179\u2013188 (1936).","journal-title":"Annals of Eugenics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07705-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07705-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07705-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T21:13:21Z","timestamp":1671570801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07705-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7705"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07705-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5233"}}